BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 6293990)

  • 1. The immunopathology of myasthenia gravis.
    Engel AG
    Int J Neurol; 1980; 14(1):35-46. PubMed ID: 6293990
    [No Abstract]   [Full Text] [Related]  

  • 2. Experimental myasthenia gravis: a model of receptor disease.
    Takamori M; Kasai M
    Int J Neurol; 1980; 14(1):47-60. PubMed ID: 6293991
    [No Abstract]   [Full Text] [Related]  

  • 3. Ultrastructural localization of immune complexes (IgG and C3) at the end-plate in experimental autoimmune myasthenia gravis.
    Sahashi K; Engel AG; Linstrom JM; Lambert EH; Lennon VA
    J Neuropathol Exp Neurol; 1978; 37(2):212-23. PubMed ID: 147324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunopathological basis of acetylcholine receptor deficiency in myasthenia gravis.
    Engel AG
    Prog Brain Res; 1979; 49():423-34. PubMed ID: 515440
    [No Abstract]   [Full Text] [Related]  

  • 5. [Myasthenia gravis and autoimmunity].
    Ergüven S
    Mikrobiyol Bul; 1986 Apr; 20(2):105-8. PubMed ID: 3773796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immunopathology of myasthenia gravis.
    Lennon VA
    Hum Pathol; 1978 Sep; 9(5):541-51. PubMed ID: 309428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-function correlations in myasthenia gravis and a new myasthenic syndrome.
    Engel AG; Lambert EH
    Electroencephalogr Clin Neurophysiol Suppl; 1978; (34):469-77. PubMed ID: 220007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunologic studies of the role of cholinergic receptors in the pathogenesis of myasthenia gravis].
    Członkowski A; Członkowska A
    Neurol Neurochir Pol; 1978; 12(5):633-7. PubMed ID: 214726
    [No Abstract]   [Full Text] [Related]  

  • 9. Passively transferred experimental autoimmune myasthenia gravis. Sequential and quantitative study of the motor end-plate fine structure and ultrastructural localization of immune complexes (IgG and C3), and of the acetylcholine receptor.
    Engel AG; Sakakibara H; Sahashi K; Lindstrom JM; Lambert EH; Lennon VA
    Neurology; 1979 Feb; 29(2):179-88. PubMed ID: 571062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myasthenia gravis and acetylcholine receptor: autoimmunity and steroid effects.
    Abramsky O
    Int J Neurol; 1980; 14(1):25-34. PubMed ID: 6293989
    [No Abstract]   [Full Text] [Related]  

  • 11. Electrophysiological studies of thymectomized and nonthymectomized acetylcholine receptor-immunized animal models of myasthenia gravis.
    Niemi WD; Nastuk WL; Chang HW; Penn AS; Rosenberry TL
    Exp Neurol; 1979 Jan; 63(1):1-27. PubMed ID: 223859
    [No Abstract]   [Full Text] [Related]  

  • 12. Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis.
    Shiraishi H; Motomura M; Yoshimura T; Fukudome T; Fukuda T; Nakao Y; Tsujihata M; Vincent A; Eguchi K
    Ann Neurol; 2005 Feb; 57(2):289-93. PubMed ID: 15668981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphologic and immunopathologic findings in myasthenia gravis and in congenital myasthenic syndromes.
    Engel AG
    J Neurol Neurosurg Psychiatry; 1980 Jul; 43(7):577-89. PubMed ID: 6249893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental myasthenia: lack of correlation between the autoantibody titer and the reduction of acetylcholine-controlled ionic channels measured at functioning endplates.
    Hohlfeld R; Sterz R; Kalies I; Wekerle H; Peper K
    Muscle Nerve; 1983 Feb; 6(2):160-3. PubMed ID: 6304508
    [No Abstract]   [Full Text] [Related]  

  • 15. [Myasthenia gravis. Prototype of an anti-receptor autoaggression disease (author's transl)].
    Hohlfeld R; Wekerle H
    MMW Munch Med Wochenschr; 1981 Jul; 123(31):1207-11. PubMed ID: 6790965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunopathology of myasthenia gravis.
    Drachman DB
    Fed Proc; 1979 Nov; 38(12):2613-5. PubMed ID: 227751
    [No Abstract]   [Full Text] [Related]  

  • 17. Immune complexes (IgG and C3) at the motor end-plate in myasthenia gravis: ultrastructural and light microscopic localization and electrophysiologic correlations.
    Engel AG; Lambert EH; Howard FM
    Mayo Clin Proc; 1977 May; 52(5):267-80. PubMed ID: 870771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myasthenia gravis: further electrophysiological and ultrastructural analysis of transmission failure in the mouse passive transfer model.
    Toyka KV; Birnberger KL; Anzil AP; Schlegel C; Besinger U; Struppler A
    J Neurol Neurosurg Psychiatry; 1978 Aug; 41(8):746-53. PubMed ID: 210263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunology of myasthenia gravis.
    Biesecker G; Koffler D
    Hum Pathol; 1983 May; 14(5):419-23. PubMed ID: 6840752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical significance of immune complexes at the motor endplate in myasthenia gravis].
    Tsujihata M; Yoshimura T; Satoh A; Hazama R; Mori M
    Rinsho Shinkeigaku; 1983 Sep; 23(9):735-43. PubMed ID: 6673871
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.